Protein Design Labs antibodies news

PDLI said the opposition division of the European Patent Office (EPO) upheld the company's European Patent No. EP 0 451 216 covering antibody humanization. The company said the patent is now "virtually identical" to when the opposition was first brought by 18 companies in 1996. The 12 opponents of the '216 patent that remain, including Novartis AG (NVS; SWX:NOVN, Basel, Switzerland) and Boehringer Ingelheim GmbH (Ingelheim, Germany), could appeal the decision. ...